![]() |
![]() |
||||||||||||
|
What to expect before and during treatment What are some possible side effects of treatment What kind of special oral diet may be recommended How you may get the most benefit from treatment When your PN
|
Your doctor may perform a weekly parenteral nutrition (PN)-volume reduction evaluation during your 28-day Zorbtive® [somatropin (rDNA origin) for injection] treatment.
This is the potential for people with Short Bowel Syndrome: Less need for PN
What to expect before and during treatment |
||||||||||||
|
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed. Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling). Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications. This information is not intended to replace discussions with your healthcare professional. This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients This site contains medical information that is intended for residents of the United States © 2007 EMD Serono, Inc. All rights reserved.
|
|||||||||||||